BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 28124028)

  • 1. Optimized CRISPR-Cas9 Genome Editing for
    Zhang WW; Lypaczewski P; Matlashewski G
    mSphere; 2017; 2(1):. PubMed ID: 28124028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
    Zhang WW; Matlashewski G
    mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of CRISPR/Cas9-Mediated Genome Editing in Leishmania.
    Zhang WW; Lypaczewski P; Matlashewski G
    Methods Mol Biol; 2020; 2116():199-224. PubMed ID: 32221923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Simple and Universal System for Gene Manipulation in
    Al Abdallah Q; Ge W; Fortwendel JR
    mSphere; 2017; 2(6):. PubMed ID: 29202040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene editing and scalable functional genomic screening in
    Engstler M; Beneke T
    Elife; 2023 May; 12():. PubMed ID: 37222701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Leishmania Strains.
    Abdi Ghavidel A; Aghamiri S; Raee P; Mohammadi-Yeganeh S; Noori E; Bandehpour M; Kazemi B; Jajarmi V
    Acta Parasitol; 2024 Mar; 69(1):121-134. PubMed ID: 38127288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic Improvement of CRISPR/Cas9 Editing in
    Ng H; Dean N
    mSphere; 2017; 2(2):. PubMed ID: 28435892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of Casein Kinase 1.1 in
    Martel D; Beneke T; Gluenz E; Späth GF; Rachidi N
    Biomed Res Int; 2017; 2017():4635605. PubMed ID: 29333442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First efficient CRISPR-Cas9-mediated genome editing in Leishmania parasites.
    Sollelis L; Ghorbal M; MacPherson CR; Martins RM; Kuk N; Crobu L; Bastien P; Scherf A; Lopez-Rubio JJ; Sterkers Y
    Cell Microbiol; 2015 Oct; 17(10):1405-12. PubMed ID: 25939677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of rice essential genes by characterizing a CRISPR-edited mutation of closely related rice MAP kinase genes.
    Minkenberg B; Xie K; Yang Y
    Plant J; 2017 Feb; 89(3):636-648. PubMed ID: 27747971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Homology-Mediated CRISPR/Cas9-Based Method for Genome Editing in Fission Yeast.
    Hayashi A; Tanaka K
    G3 (Bethesda); 2019 Apr; 9(4):1153-1163. PubMed ID: 30755408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a CRISPR-Cas9 System for Efficient Genome Editing of
    Norton EL; Sherwood RK; Bennett RJ
    mSphere; 2017; 2(3):. PubMed ID: 28657072
    [No Abstract]   [Full Text] [Related]  

  • 15. Cas9/gRNA-mediated genome editing of yeast mitochondria and
    Yoo BC; Yadav NS; Orozco EM; Sakai H
    PeerJ; 2020; 8():e8362. PubMed ID: 31934513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Mediated Targeted Knockin of Exogenous Reporter Genes in Zebrafish.
    Kawahara A
    Methods Mol Biol; 2017; 1630():165-173. PubMed ID: 28643258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Enabled Multiplex Genome Editing and Its Application.
    Minkenberg B; Wheatley M; Yang Y
    Prog Mol Biol Transl Sci; 2017; 149():111-132. PubMed ID: 28712493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient SSA-mediated precise genome editing using CRISPR/Cas9.
    Li X; Bai Y; Cheng X; Kalds PGT; Sun B; Wu Y; Lv H; Xu K; Zhang Z
    FEBS J; 2018 Sep; 285(18):3362-3375. PubMed ID: 30085411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluation of CRISPR PX-LmGP63 vector effect on pathogenicity of Leishmania major as a primary step to control leishmaniasis.
    Ebrahimi S; Kalantari M; Alipour H; Azizi K; Asgari Q; Bahreini MS
    Microb Pathog; 2021 Dec; 161(Pt A):105281. PubMed ID: 34752910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.